Our results demonstrate that the T22-PE24-H6 nanotoxin displays a potent CXCR4-dependent cytotoxic effect in CRC cells and also that its use at low doses in a repeated treatment regime is capable of inhibiting tumor growth and metastasis development without associated systemic toxicity. The gene discussed is CXCR4; the disease is neoplasm.